Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.
Norden AD; Lesser GJ; Drappatz J; Ligon KL; Hammond SN; Lee EQ; Reardon DR; Fadul CE; Plotkin SR; Batchelor TT; Zhu JJ; Beroukhim R; Muzikansky A; Doherty L; Lafrankie D; Smith K; Tafoya V; Lis R; Stack EC; Rosenfeld MR; Wen PY; Neuro-Oncology, 2013, vol. 15, issue 7, p 930, ISSN 15235866. ISBN 15235866.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef